IBDEI1DB ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24234,1,2,0)
 ;;=2^OSTEOMYELITIS NOS-UNSPEC
 ;;^UTILITY(U,$J,358.3,24234,2)
 ;;=^87108
 ;;^UTILITY(U,$J,358.3,24235,0)
 ;;=420.90^^133^1476^13
 ;;^UTILITY(U,$J,358.3,24235,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24235,1,1,0)
 ;;=1^420.90
 ;;^UTILITY(U,$J,358.3,24235,1,2,0)
 ;;=2^PERICARDITIS,ACUTE,UNSPEC
 ;;^UTILITY(U,$J,358.3,24235,2)
 ;;=^269692
 ;;^UTILITY(U,$J,358.3,24236,0)
 ;;=481.^^133^1476^15
 ;;^UTILITY(U,$J,358.3,24236,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24236,1,1,0)
 ;;=1^481.
 ;;^UTILITY(U,$J,358.3,24236,1,2,0)
 ;;=2^PNEUMONIA,PNEUMOCOCCAL
 ;;^UTILITY(U,$J,358.3,24236,2)
 ;;=^95612
 ;;^UTILITY(U,$J,358.3,24237,0)
 ;;=486.^^133^1476^14
 ;;^UTILITY(U,$J,358.3,24237,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24237,1,1,0)
 ;;=1^486.
 ;;^UTILITY(U,$J,358.3,24237,1,2,0)
 ;;=2^PNEUMONIA, ORGANISM NOS
 ;;^UTILITY(U,$J,358.3,24237,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,24238,0)
 ;;=038.9^^133^1476^17
 ;;^UTILITY(U,$J,358.3,24238,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24238,1,1,0)
 ;;=1^038.9
 ;;^UTILITY(U,$J,358.3,24238,1,2,0)
 ;;=2^SEPSIS
 ;;^UTILITY(U,$J,358.3,24238,2)
 ;;=^109318
 ;;^UTILITY(U,$J,358.3,24239,0)
 ;;=995.90^^133^1476^18
 ;;^UTILITY(U,$J,358.3,24239,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24239,1,1,0)
 ;;=1^995.90
 ;;^UTILITY(U,$J,358.3,24239,1,2,0)
 ;;=2^SYSTEM INFLAM RESPONSE SYNDROM
 ;;^UTILITY(U,$J,358.3,24239,2)
 ;;=^328611
 ;;^UTILITY(U,$J,358.3,24240,0)
 ;;=136.9^^133^1476^9
 ;;^UTILITY(U,$J,358.3,24240,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24240,1,1,0)
 ;;=1^136.9
 ;;^UTILITY(U,$J,358.3,24240,1,2,0)
 ;;=2^INFECTIOUS CONDITIONS NEC
 ;;^UTILITY(U,$J,358.3,24240,2)
 ;;=^123934
 ;;^UTILITY(U,$J,358.3,24241,0)
 ;;=480.9^^133^1476^16
 ;;^UTILITY(U,$J,358.3,24241,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24241,1,1,0)
 ;;=1^480.9
 ;;^UTILITY(U,$J,358.3,24241,1,2,0)
 ;;=2^PNEUMONIA,VIRAL
 ;;^UTILITY(U,$J,358.3,24241,2)
 ;;=^95657
 ;;^UTILITY(U,$J,358.3,24242,0)
 ;;=V71.89^^133^1477^1
 ;;^UTILITY(U,$J,358.3,24242,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24242,1,1,0)
 ;;=1^V71.89
 ;;^UTILITY(U,$J,358.3,24242,1,2,0)
 ;;=2^OBSERV OTH SPEC SUSPEC COND
 ;;^UTILITY(U,$J,358.3,24242,2)
 ;;=^322082
 ;;^UTILITY(U,$J,358.3,24243,0)
 ;;=99377^^134^1478^1^^^^1
 ;;^UTILITY(U,$J,358.3,24243,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24243,1,1,0)
 ;;=1^99377
 ;;^UTILITY(U,$J,358.3,24243,1,2,0)
 ;;=2^Hospice Care Supervision,15-29 min
 ;;^UTILITY(U,$J,358.3,24244,0)
 ;;=99378^^134^1478^2^^^^1
 ;;^UTILITY(U,$J,358.3,24244,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24244,1,1,0)
 ;;=1^99378
 ;;^UTILITY(U,$J,358.3,24244,1,2,0)
 ;;=2^Hospice Care Supervision,30 min or more
 ;;^UTILITY(U,$J,358.3,24245,0)
 ;;=G0182^^134^1478^12^^^^1
 ;;^UTILITY(U,$J,358.3,24245,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24245,1,1,0)
 ;;=1^G0182
 ;;^UTILITY(U,$J,358.3,24245,1,2,0)
 ;;=2^Hospice Care-Use with each encounter
 ;;^UTILITY(U,$J,358.3,24246,0)
 ;;=S0257^^134^1479^1^^^^1
 ;;^UTILITY(U,$J,358.3,24246,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24246,1,1,0)
 ;;=1^S0257
 ;;^UTILITY(U,$J,358.3,24246,1,2,0)
 ;;=2^End of Life Counseling
 ;;^UTILITY(U,$J,358.3,24247,0)
 ;;=98960^^134^1480^1^^^^1
 ;;^UTILITY(U,$J,358.3,24247,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24247,1,1,0)
 ;;=1^98960
 ;;^UTILITY(U,$J,358.3,24247,1,2,0)
 ;;=2^Self-Mgmt Educ/Train,1 Pt
 ;;^UTILITY(U,$J,358.3,24248,0)
 ;;=98961^^134^1480^2^^^^1
 ;;^UTILITY(U,$J,358.3,24248,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24248,1,1,0)
 ;;=1^98961
 ;;^UTILITY(U,$J,358.3,24248,1,2,0)
 ;;=2^Self-Mgmt Educ/Train,2-4 Pts
 ;;
 ;;$END ROU IBDEI1DB
